In a sector that has continued to remain in growth mode, it’s important to ensure that organizations meet the regulatory standards set forth. Reinvesting profits can help you take advantage of a trending marketplace. At KPMG, we help clients meet regulatory guidelines, revitalize telehealth platforms, and increase member utilization and loyalty. Our professionals are dedicated to driving member satisfaction and shifting from transactional interactions to personal outcomes leading to higher retention and lower appeals.
Insights for the Healthcare Payors Sub Sector
Capitalize on the evolving landscape in the payor sector.
Our latest thinking related to Payors
No results found.
Insight
Key trends for PE firms in healthcare and life sciences
Competition in healthcare is intense, but PE firms can succeed if they understand the post-covid ecosystem, say KPMG’s Kristin Pothier and Glenn Mincey.
Insight
The FDA’s guidance on Computer Software Assurance (CSA) for life sciences one year later
Life sciences webcast
Insight
How to make the most of a downturn in Healthcare & Life Sciences
Join KPMG January 17 for a webcast focused on how healthcare and life sciences experts can prepare for a potential recession and actions that will strengthen resilience.
Insight
FDA's Accelerated Approval Program: Accelerated Pathway for Reform?
Reforms to FDA Accelerated Approval Program could include new confirmatory study requirements.
Insight
6 Industry use cases for intelligent forecasting
Learn about the real-world use cases of intelligent forecasting
Insight
GenAI is poised to transform healthcare. Is healthcare ready?
The fast-moving tech’s revolutionary potential promises to redefine a massive industry and its slow-mover history—and the stakes have never been higher.
Insight
2024 Healthcare and Life Sciences Investment Outlook
We analyze how eight subsectors fared and how deal activity and market drivers could shape the 2024 investment landscape.
Insight
KPMG’s Healthcare and Life Sciences Strategy practice overview
Our Strategy practice is global, delivering solutions informed by our industry depth and local market knowledge
Insight
How data and analytics are transforming healthcare
Innovations from the pandemic are now being applied to new challenges, including disparities in the delivery of health services.
Insight
How evolving market conditions are shaping healthcare and PE
KPMG hosts a Twitter Spaces conversation exploring the intersection of healthcare and private equity.
Insight
In vitro diagnostics deal making
Smaller Deals, More Partnerships, and Continued Innovation in 2022.
Insight
The convergence of the tech and healthcare sectors
How tech, NFTs, cyber security, and talent are impacting the healthcare industry
Insight
The future of sales for healthcare and life sciences
Emerge stronger with realigned sales models and improved performance
Insight
Blog 3: Quality Management Software in the age of the “Great Resignation”
Find out how new age digital quality management can help life sciences organizations retain talent and meet business objectives
Insight
Shifting from compliance to quality
Taking steps toward adopting computer software assurance (CSA) in life sciences
Insight
Consumer/Worker Protections: FTC, FCC, and DOL Sign MOUs
Agreements to protect consumers from electronic spam/scams and workers from unfair competition/business practices
Insight
5 key challenges and roadblocks in biopharma commercial models
How pharmaceutical sales models impact revenue growth
Insight
Precision medicine: Data optimized. Potential realized.
Is your enterprise data optimized for precision medicine? Break down siloes to achieve breakthrough outcomes.
Insight
Tax Considerations for the Life Cycle of Emerging Bio Companies
A KPMG Life Sciences Webcast
Insight
The ‘new normal’ demands new front office strategies
To understand the impact and aftereffects of COVID-19 on life sciences organizations and how the front office must retool for this “new normal,” the KPMG Sales Transformation team conducted a pulse survey of almost 100 providers
Insight
Podcast and Webcast
Listen to our latest podcasts and webcasts
Insight
Conferences
Learn more about our Conferences
Insight
Operations
KPMG leverages a holistic approach, helping organizations design and align operating models with business strategy.
Insight
Is deal making ready to rebound? M&A trends in healthcare
Is deal making ready to rebound? M&A trends in healthcare
Insight
How HCLS firms can thrive during the downturn
Healthcare and life sciences leaders should be making four moves now to weather the economic downturn and set the stage for new growth
Insight
Trends and best practices for launching therapeutics in Europe
Please join us for the next installment of our monthly life sciences tax webcast series by KPMG LLP (KPMG) on how to optimize your biotechnology launch in Europe.
Insight
Healthcare and life sciences M&A: Poised for a rebound?
After a wild few years for HCLS, there’s reason for optimism and some new opportunities—if you know where to look.
Insight
KPMG 2023 Healthcare and Life Sciences Investment Outlook
Our 2023 Healthcare and Life Sciences Investment Outlook finds turbulence, and opportunity, in this post-pandemic marketplace.
Insight
How to make the most of a downturn: Healthcare & Life Sciences
Healthcare & life sciences firms that take strong action before a downturn—and invest during a slump—are more likely to outperform.
Insight
How to make the most of a downturn: Healthcare & Life Sciences
Healthcare & life sciences firms that take strong action before a downturn—and invest during a slump—are more likely to outperform.
Insight
Liquid Biopsy – What’s real and what’s hype?
KPMG perspective on this innovative technology
Insight
503B outsourcing facilities and pharma manufacturers
Why the growth of 503Bs may be an opportunity for traditional pharma
